Article Versions Notes

Wuputra K, Hsiao P-J, Chang W-T, Wu P-H, Chen L-A, Huang J-W, Su W-L, Yang Y-H, Wu D-C, Yokoyama KK, et al. FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells. International Journal of Molecular Sciences. 2022; 23(14):7782. https://doi.org/10.3390/ijms23147782

Wuputra, Kenly, Pi-Jung Hsiao, Wen-Tsan Chang, Po-Hsuan Wu, Lin-Ann Chen, Jian-Wei Huang, Wen-Lung Su, Ya-Han Yang, Deng-Chyang Wu, Kazunari K. Yokoyama, and et al. 2022. "FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells" International Journal of Molecular Sciences 23, no. 14: 7782. https://doi.org/10.3390/ijms23147782

Wuputra, K., Hsiao, P.-J., Chang, W.-T., Wu, P.-H., Chen, L.-A., Huang, J.-W., Su, W.-L., Yang, Y.-H., Wu, D.-C., Yokoyama, K. K., & Kuo, K.-K. (2022). FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells. International Journal of Molecular Sciences, 23(14), 7782. https://doi.org/10.3390/ijms23147782